Abstract
Introduction & Objectives Meniscal injuries occur approximately 66 to 70 per 100,000 individuals annually (Fig. 1), potentially leading to the development of osteoarthritis (OA) or other degenerative cartilage disease in 10 to 20 years. One of the conventional treatments is meniscal allograft transplantation. However, its limitations constrain its comprehensive application in the healthcare system.
Original language | English |
---|---|
Pages | 1-1 |
Number of pages | 1 |
Publication status | Published - Jun 2025 |
Event | 33rd Annual Meeting of the European Orthopaedic Research Society (EORS) - Davos, Switzerland Duration: 16 Jun 2025 → 19 Jun 2025 |
Conference
Conference | 33rd Annual Meeting of the European Orthopaedic Research Society (EORS) |
---|---|
Abbreviated title | EORS 2025 |
Country/Territory | Switzerland |
City | Davos |
Period | 16/06/25 → 19/06/25 |